This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignees: Shanghai Aryl Pharmtech Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 2 
1 out of 3 Years Active: 2026
Title: The Innovative Contributions of Daiwang Xu
Introduction
Daiwang Xu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. His work focuses on innovative compounds that have the potential to improve medical treatments.
Latest Patents
Daiwang Xu holds a patent for a "Salt of tetrahydroisoquinoline derivative, preparation method therefor, and medical use thereof." This invention relates to a pharmaceutically acceptable salt of (S)-2-(6-fluorobenzo[d]oxazol-2-yl)-6-methoxy-5-((5-methoxypyridin-2-yl))methoxy)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid. The patent outlines a preparation method, a pharmaceutical composition comprising the salt, and its use as a therapeutic agent, specifically as an angiotensin II type-2 receptor antagonist. This innovation highlights his commitment to advancing medical science.
Career Highlights
Throughout his career, Daiwang Xu has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Zhejiang Hisun Pharmaceutical Co., Ltd. and Shanghai Aryl Pharmtech Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Due to space constraints, the details of collaborations will not be included in this article.
Conclusion
Daiwang Xu's contributions to the field of pharmaceuticals through his innovative patent and career in reputable companies underscore his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.